Agenda

                          Understanding & Drugging RAS --Are we there yet?

 

Tuesday, October 8

 

9:00 am – 9:50 am       Introduction & Welcome from 

  • W. Kimryn Rathmell, National Cancer Institute
  • Douglas R. Lowy, National Cancer Institute
  • Frank McCormick, Frederick National Lab, University of California, San Francisco    
  • Remarks from Terri Conneran, founder of KRAS Kickers                                    

9:50 am – 12:10 pm     Session 1: RAS Therapeutics

  • Mariano Barbacid, Spanish National Cancer Research Center (CNIO)
  • Andy Aguirre, Dana-Farber Cancer Institute
  • Mallika Singh, Revolution Medicines
  • Robert Vonderheide, University of Pennsylvania
  • Ziyang Zhang, University of California, Berkeley                                        

12:15 pm – 3:15 pm    Lunch/Poster Session/Meet the Expert Sessions

3:15pm – 4:55 pm        Session 2: RAS Effectors 

  • Dhirendra Simanshu, Frederick National Lab
  • Pedro Beltran, BridgeBio Oncology Therapeutics                  
  • Lucy Young, University of California, San Francisco
  • Debbie Morrison, National Cancer Institute, Center for Cancer Research

 

Wednesday, October 9

 

9:00am – 9:30 am      Special Remarks from Margaret Foti, AACR Chief Executive Officer

9:30am – 11:50 am      Session 3: Biochemistry and Regulation of GTPases

  • Andy Stephen, Frederick National Lab
  • Brigitte Wideman, National Cancer Institute, Center for Cancer Research 
  • Guillermo Calero, University of Pittsburgh School of Medicine 

11:50 pm – 2:45 pm    Lunch/Poster Session/Meet the Expert Sessions

2:45 pm – 4:50 pm       Session 4: RAS and Entangled Pathways

  • Greg Jones, Pfizer         
  • Channing Der, University of North Carolina 
  • Xose Bustelo, Salamanca Cancer Research Center (CIC)
  • Pau Castel, New York University, Langone Health
  • Daniel Bonsor, Frederick National Lab

4:50 pm – 5:50 pm       Session 5: RAS in Membranes

  • Moitrayee Bhattacharyya, Yale University
  • Yong Zhou, University of Texas Health Science Center
  • Gaudenz Danuser, UT Southwestern

5:50 pm – 8:00 pm      Networking Event

             Rockwell Brewery (ticketed event, pre-payment required)

 

Thursday, October 10

 

9:00 am – 11:10 am     Panel Discussion

  • Mallika Singh, Revolution Medicines
  • Cameron Pitt, Quanta Therapeutics
  • James Christensen, Mirati

            Session 6:  Where are we and Next Steps     

  • Piro Lito, Memorial Sloan Kettering Cancer Center 
  • Kevan Shokat, University of California, San Francisco

11:10 am – 11:25 am  RAS Symposium Wrap Up and Highlights

  • Frank McCormick, Frederick National Lab, University of California, San Francisco

 

        Pediatric Mini Symposium

11:25am – 11:45 am   Introduction

11:45 am – 12:45 pm  Lunch & Networking

12:45 pm – 3:00 pm    Targeting RAS in Solid Tumors

  • Meredith Irwin, The Hospital for Sick Children
  • Sameer Agnihotri, UPMC Children’s Hospital of Pittsburgh
  • Carlos Prada, Lurie Children’s Hospital 

3:00 pm – 4:50 pm       Targeting RAS in Hematologic Malignancies

  • Nicolas Nassar, Cincinnati Children’s Hospital
  • Yana Pikman, Dana-Farber Cancer Institute
  • Elliot Stieglitz, UCSF Benioff Children’s Hospitals

4:50pm – 5:00 pm       Concluding Remarks, Mini-Symposium Wrap Up